A Safety and Efficacy Study of DRM02 in Subjects With Rosacea

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether DRM02 is safe and effective in the treatment of rosacea when applied twice daily for 6 weeks.

Phase 2

Dermira, Inc.